Summary

Global Meningitis Diagnostic Testing Market is valued approximately at USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than 3.8% over the forecast period 2021-2027. Meningitis is a medical disease in which the membranes that surround a person's brain and spinal cord become inflamed. Symptoms of swollen meningitis include headaches, fever, and stiffness in the neck. Meningitis can be caused by a variety of causes, including ear infections, skull fractures, and, in rare cases, surgery. Additionally, germs that enter the circulation and move to the brain and spinal cord, causing acute bacterial meningitis, or bacteria that directly infect the meninges, can cause of meningitis diagnostic. The market is driven by the key factors such as Increased Demand for Advanced Diagnostics for Sensitive Reports and Accurate Diagnosis and Rise in the Global Prevalence of Meningitis. Furthermore, The rise in worldwide incidence of infectious illnesses and HIV, which is one of the leading causes of meningitis. According to the United Nations Programme on HIV/AIDS (UNAIDS), 24.5 million individuals living with HIV received antiretroviral treatment in 2019. Also, According to WHO, As of April 2021, 24 of the 26 countries in the meningitis belt had launched nationwide or in high-risk areas large preventative programmes targeting 1-29 year olds, and half of them had included this vaccine in their national regular vaccination schedules. The prevalence of serogroup A meningitis has decreased by more than 99 percent among vaccinated populations, with no confirmed cases since 2017. However, Lack of Awareness Regarding of Diagnosis and Availability of Diagnostic Laboratories In Developing Countries, may impede market growth over the forecast period of 2021-2027.

During the projected period, North America is expected to dominate the worldwide meningitis diagnostic testing market. The market in North America is expected to be fueled by a high acceptance rate of advanced diagnostic equipment, a growth in the number of diagnostic facilities, and the accessibility of diagnostic test kits.

Major market player included in this report are:
Seegene Inc.
Abbott Laboratories
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories Inc.
Siemens Healthineers AG
Becton, Dickinson and Company
ELITechGroup
IMMY
Luminex Corporation




The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Test Type:
Latex Agglutination Tests
Lateral Flow Assay
PCR Assay
ELISA Tests
Culture Test
Others
By End User:
Hospital
Diagnostic Center
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.

Target Audience of the Global Meningitis Diagnostic Testing Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

ページTOPに戻る

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Meningitis Diagnostic Testing Market, by Region, 2019-2027 (USD Billion)
1.2.2. Meningitis Diagnostic Testing Market, by Test Type, 2019-2027 (USD Billion)
1.2.3. Meningitis Diagnostic Testing Market, by End User, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Meningitis Diagnostic Testing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Meningitis Diagnostic Testing Market Dynamics
3.1. Meningitis Diagnostic Testing Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increased Demand for Advanced Diagnostics for Sensitive Reports and Accurate Diagnosis
3.1.1.2. Rise in the Global Prevalence of Meningitis
3.1.2. Market Restraint
3.1.2.1. Lack of Awareness Regarding of Diagnosis and Availability of Diagnostic Laboratories In Developing Countries
3.1.2.2. Complex Regulatory Framework by Authorities
3.1.3. Market Opportunities
3.1.3.1. Increase in frequencies of research and development activities
3.1.3.2. Rapid technological upgradations
Chapter 4. Global Meningitis Diagnostic Testing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Meningitis Diagnostic Testing Market, by Test Type
5.1. Market Snapshot
5.2. Global Meningitis Diagnostic Testing Market by Test Type , Performance - Potential Analysis
5.3. Global Meningitis Diagnostic Testing Market Estimates & Forecasts by Test Type 2018-2027 (USD Billion)
5.4. Meningitis Diagnostic Testing Market , Sub Segment Analysis
5.4.1. Latex Agglutination Tests
5.4.2. Lateral Flow Assay
5.4.3. PCR Assay
5.4.4. ELISA Tests
5.4.5. Culture Test
5.4.6. Others
Chapter 6. Global Meningitis Diagnostic Testing Market, by End User
6.1. Market Snapshot
6.2. Global Meningitis Diagnostic Testing Market by End User, Performance - Potential Analysis
6.3. Global Meningitis Diagnostic Testing Market Estimates & Forecasts by End User 2018-2027 (USD Billion)
6.4. Meningitis Diagnostic Testing Market , Sub Segment Analysis
6.4.1. Hospital
6.4.2. Diagnostic Center
6.4.3. Others
Chapter 7. Global Meningitis Diagnostic Testing Market, Regional Analysis
7.1. Meningitis Diagnostic Testing Market , Regional Market Snapshot
7.2. North America Meningitis Diagnostic Testing Market
7.2.1. U.S. Meningitis Diagnostic Testing Market
7.2.1.1. Test Type breakdown estimates & forecasts, 2018-2027
7.2.1.2. End User breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Meningitis Diagnostic Testing Market
7.3. Europe Meningitis Diagnostic Testing Market Snapshot
7.3.1. U.K. Meningitis Diagnostic Testing Market
7.3.2. Germany Meningitis Diagnostic Testing Market
7.3.3. France Meningitis Diagnostic Testing Market
7.3.4. Spain Meningitis Diagnostic Testing Market
7.3.5. Italy Meningitis Diagnostic Testing Market
7.3.6. Rest of Europe Meningitis Diagnostic Testing Market
7.4. Asia-Pacific Meningitis Diagnostic Testing Market Snapshot
7.4.1. China Meningitis Diagnostic Testing Market
7.4.2. India Meningitis Diagnostic Testing Market
7.4.3. Japan Meningitis Diagnostic Testing Market
7.4.4. Australia Meningitis Diagnostic Testing Market
7.4.5. South Korea Meningitis Diagnostic Testing Market
7.4.6. Rest of Asia Pacific Meningitis Diagnostic Testing Market
7.5. Latin America Meningitis Diagnostic Testing Market Snapshot
7.5.1. Brazil Meningitis Diagnostic Testing Market
7.5.2. Mexico Meningitis Diagnostic Testing Market
7.6. Rest of The World Meningitis Diagnostic Testing Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. BioFire Diagnostics LLC
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Seegene Inc.
8.2.3. Abbott Laboratories
8.2.4. Thermo Fisher Scientific Inc.
8.2.5. Bio-Rad Laboratories Inc.
8.2.6. Siemens Healthineers AG
8.2.7. Becton, Dickinson and Company
8.2.8. ELITechGroup
8.2.9. IMMY
8.2.10. Luminex Corporation
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption